RYGENERA RESEARCH LIMITEDActive
Key figures
Amounts are in EUR (the currency of the accounts).
Like most small UK companies, RYGENERA RESEARCH LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025Balance sheet structure
Filed accounts2019–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | — |
| Profit for the year | — | — | — | — | — |
| Total assets | 162,137 | 135,374 | 11,166 | 48,259 | 44,996 |
| Total liabilities | — | 79,266 | — | — | — |
| Net assets / total equity | 85,295 | 71,345 | -8,480 | -1,912 | 41,417 |
| Average number of employees | 0 | 0 | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: RYGENERA RESEARCH LIMITED
Company
RYGENERA RESEARCH LIMITED is a private limited company registered with Companies House under company number 06845554. It was incorporated on 12 Mar 2009. Its status is active. The registered office is in London (SE12). Its nature of business (SIC 2007) is other human health activities (86900).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files micro-entity accounts. Net assets were 41,417 EUR, up 2,266.2% on the previous year. The company had an average of 0 employees. Figures are available for 7 financial years (2019–2025).
Control and charges
The company has 1 current director. One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 7 Nov 2026.